ATE296815T1 - Substituierte benzylthiazolidin-2,4-dion derivate - Google Patents

Substituierte benzylthiazolidin-2,4-dion derivate

Info

Publication number
ATE296815T1
ATE296815T1 AT00953477T AT00953477T ATE296815T1 AT E296815 T1 ATE296815 T1 AT E296815T1 AT 00953477 T AT00953477 T AT 00953477T AT 00953477 T AT00953477 T AT 00953477T AT E296815 T1 ATE296815 T1 AT E296815T1
Authority
AT
Austria
Prior art keywords
dione derivatives
unsubstituted
substituted benzylthiazolidine
substituents
action
Prior art date
Application number
AT00953477T
Other languages
English (en)
Inventor
Hiroyuki Miyachi
Masahiro Nomura
Takahiro Tanase
Koji Murakami
Masaki Tsunoda
Original Assignee
Kyorin Seiyaku Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyorin Seiyaku Kk filed Critical Kyorin Seiyaku Kk
Application granted granted Critical
Publication of ATE296815T1 publication Critical patent/ATE296815T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/34Oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
AT00953477T 1999-08-23 2000-08-18 Substituierte benzylthiazolidin-2,4-dion derivate ATE296815T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP23552999 1999-08-23
JP2000242707 2000-08-10
PCT/JP2000/005521 WO2001014351A1 (en) 1999-08-23 2000-08-18 Substituted benzylthiazolidine-2,4-dione derivatives

Publications (1)

Publication Number Publication Date
ATE296815T1 true ATE296815T1 (de) 2005-06-15

Family

ID=26532181

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00953477T ATE296815T1 (de) 1999-08-23 2000-08-18 Substituierte benzylthiazolidin-2,4-dion derivate

Country Status (10)

Country Link
US (1) US6734199B1 (de)
EP (1) EP1207157B1 (de)
KR (1) KR100700304B1 (de)
CN (1) CN1167691C (de)
AT (1) ATE296815T1 (de)
AU (1) AU778721B2 (de)
CA (1) CA2382573C (de)
DE (1) DE60020573T2 (de)
HU (1) HUP0202701A3 (de)
WO (1) WO2001014351A1 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI262185B (en) * 1999-10-01 2006-09-21 Eisai Co Ltd Carboxylic acid derivatives having anti-hyperglycemia and anti-hyperlipemia action, and pharmaceutical composition containing the derivatives
US6982251B2 (en) 2000-12-20 2006-01-03 Schering Corporation Substituted 2-azetidinones useful as hypocholesterolemic agents
US7071181B2 (en) 2001-01-26 2006-07-04 Schering Corporation Methods and therapeutic combinations for the treatment of diabetes using sterol absorption inhibitors
HU230253B1 (hu) 2001-01-26 2015-11-30 Merck Sharp & Dohme Corp Peroxiszóma proliferátor-aktivált receptor (PPAR) aktivátor(ok) és szterin-abszorpció inhibitor(ok) kombinációi és alkalmazásuk vaszkuláris indikációk kezelésére
DK1355644T3 (da) 2001-01-26 2006-10-23 Schering Corp Anvendelse af substituerede azetidinonforbindelser til behandling af sitosterolæmi
US7507767B2 (en) * 2001-02-08 2009-03-24 Schering Corporation Cannabinoid receptor ligands
US7053080B2 (en) 2001-09-21 2006-05-30 Schering Corporation Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors
US7056906B2 (en) 2001-09-21 2006-06-06 Schering Corporation Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women
JP2005504091A (ja) 2001-09-21 2005-02-10 シェーリング コーポレイション ステロール吸収阻害剤としてアゼチジノンを用いる黄色腫の処置
WO2003068205A1 (en) * 2002-02-14 2003-08-21 Kirin Beer Kabushiki Kaisha Compositions and foods for improving lipid metabolism
AU2003225027A1 (en) * 2002-04-16 2003-11-03 Merck And Co., Inc. Combination therapy using a ppar alpha/gamma agonist
WO2004043457A1 (en) 2002-11-06 2004-05-27 Schering Corporation Cholesterol absorptions inhibitors for the treatment of autoimmune disorders
JP2006519869A (ja) 2003-03-07 2006-08-31 シェーリング コーポレイション 置換アゼチジノン化合物、置換アゼチジノン化合物を調製するためのプロセス、それらの処方物および使用
CA2517571C (en) 2003-03-07 2011-07-05 Schering Corporation Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
US7459442B2 (en) 2003-03-07 2008-12-02 Schering Corporation Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
JP4589919B2 (ja) 2003-03-07 2010-12-01 シェーリング コーポレイション 高コレステロール血症の処置のための、置換アゼチジノン化合物、これらの処方物および使用
KR20050068860A (ko) 2003-12-30 2005-07-05 엘지.필립스 엘시디 주식회사 듀얼 플레이트 유기전계 발광소자용 상부기판 및 그의제조방법
AU2005272389B2 (en) * 2004-08-11 2011-08-04 Kyorin Pharmaceutical Co., Ltd. Novel cyclic aminobenzoic acid derivative
JPWO2006101108A1 (ja) * 2005-03-23 2008-09-04 杏林製薬株式会社 新規環状アミノフェニルアルカン酸誘導体

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989008650A1 (en) * 1988-03-08 1989-09-21 Pfizer Inc. Thiazolidinedione hypoglycemic agents
JP3929512B2 (ja) 1995-06-02 2007-06-13 杏林製薬株式会社 N−置換ジオキソチアゾリジルベンズアミド誘導体及びその製造法
JP3144624B2 (ja) 1995-06-02 2001-03-12 杏林製薬株式会社 N−ベンジルジオキソチアゾリジルベンズアミド誘導体及びその製造法
WO1997032863A1 (en) * 1996-03-08 1997-09-12 Torii Pharmaceutical Co., Ltd. Thiazolidine-2,4-dione derivatives
IL120443A (en) 1996-03-18 2000-07-16 Sankyo Co Use of an insulin sensitizer for the manufacture of a medicament for the treatment or prophylaxis of pancreatitis
JPH09301963A (ja) 1996-05-17 1997-11-25 Kyorin Pharmaceut Co Ltd N−ベンジルジオキソチアゾリジルベンズアミド誘導体及びその製造法
GB0127805D0 (en) 2001-11-20 2002-01-09 Smithkline Beecham Plc Pharmaceutical composition

Also Published As

Publication number Publication date
DE60020573D1 (de) 2005-07-07
EP1207157B1 (de) 2005-06-01
US6734199B1 (en) 2004-05-11
DE60020573T2 (de) 2006-03-16
HUP0202701A2 (hu) 2002-12-28
CN1382128A (zh) 2002-11-27
HUP0202701A3 (en) 2004-12-28
KR100700304B1 (ko) 2007-03-29
WO2001014351A1 (en) 2001-03-01
CN1167691C (zh) 2004-09-22
CA2382573C (en) 2007-05-22
EP1207157A1 (de) 2002-05-22
AU778721B2 (en) 2004-12-16
KR20020022813A (ko) 2002-03-27
CA2382573A1 (en) 2001-03-01
EP1207157A4 (de) 2002-09-18
AU6594700A (en) 2001-03-19

Similar Documents

Publication Publication Date Title
ATE296815T1 (de) Substituierte benzylthiazolidin-2,4-dion derivate
DE60020381D1 (de) Substituierte benzylthiazolidin-2,4-dion-derivate
ATE295841T1 (de) Substituierte benzylthiazolidin-2,4-dion derivate
CY1108586T1 (el) Υποκαταστημενα παραγωγα φαινυλοπροπιονικου οξεος
MX9504349A (es) Derivados de aroilpiperidina.
KR970069985A (ko) 1,2-디페닐피롤 유도체,그의 제법 및 그의 치료학적 용도
ATE51223T1 (de) Derivate der 2-azetidinon-1-sulfonsaeure, ihre herstellung und verwendung.
ES541709A0 (es) Un procedimiento para la preparacion de derivados de fenoxi-c3-c7-alquiloxi-3,4-dihidro-2h-1-benzopirano
DE3869907D1 (de) Chinolincarbonsaeure-derivate.
ATE330930T1 (de) Neue ethylaminderivate
DK0754682T3 (da) Aminostilbazolderivat og lægemiddel
DE60002558D1 (de) Derivate der Phosphonsäure zur Inhibierung von Carboxypeptidase B
ATE296293T1 (de) Substituierte benzylthiazolidin-2,4-dion derivate
SE8802428D0 (sv) New compounds
ATE24915T1 (de) Synergistin-derivate und ihre herstellung.
NO20016366D0 (no) Mellomprodukter for syntese av benzimidazolforbindelser, og fremgangsmåte for fremstilling derav
MY128711A (en) Use of thiazole derivatives for the manufacture of a medicament for the treatment of chronic obstructive pulmonary disease
ES2110974T3 (es) Procedimiento para la preparacion de (s)-vinil y de (s)-alenil-gaba.
ATE93847T1 (de) Thioformamid-derivate.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties